Intratumoral Injectable Redox‐Responsive Immune Niche Improves the Abscopal Effect in Radiotherapy

T cells and increase antigen-specific cell-killing efficiency under in vitro immunosuppressive conditions. In vivo studies confirm TIN's ability to elicit robust systemic anticancer activity in mouse melanoma and colorectal cancer models without inducing severe immune-related adverse events.